Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,169 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

for
Neoplasms, Endometrial
Location: Montreal, Toronto, Charlottesville VA, Birmingham AL,
Sponsor: GlaxoSmithKline

Sex: Female

Age: 18+

Code: NCT07286331

Phase 3, Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Montreal, Albany NY, New Haven CT, Manhasset NY,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase 2, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

for
Neoplasms, Colorectal, Neoplasms
Location: Toronto, Montreal, Hamilton, Detroit MI, Canton OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07213609

Phase 1, Phase 2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Toronto, Montreal, Calgary, Boston MA, Rochester NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase 3, Recruiting

Open-label Extension Study in Participants With Early Alzheimer's Disease

for
Alzheimer's Disease
Location: Greenfield Park, Ottawa, Sherbrooke, Peterborough,
Sponsor: GlaxoSmithKline

Sex: All

Age: 50 - 70+

Code: NCT07105709

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

for
Ovarian Neoplasms, Breast Neoplasms
Location: Toronto, Montreal, Boston MA, Lake Success NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT04641247

Phase 2, Recruiting

A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

for
Sarcoma
Location: Toronto, Montreal, West Valley City UT
Sponsor: GlaxoSmithKline

Sex: All

Age: 0+

Code: NCT07602777

Phase 1, Phase 2, Recruiting

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

for
Tumours, Gynecological
Location: Toronto, Montreal, Rochester NY, Columbus OH, Durham NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06796907

Phase 1, Phase 2, Recruiting

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

for
Neoplasms
Location: Toronto, Montreal, Philadelphia PA, San Antonio TX
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07438782

Phase 1, Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

for
Pulmonary Disease, Chronic Obstructive
Location: Saint-Charles-Borromee, Sherbrooke, Ajax, Toronto,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT06959095

Phase 3, Recruiting

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

for
Gastrointestinal Neoplasms
Location: Toronto, Montreal, Calgary, Sherbrooke, New York NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06885034

Phase 1, Phase 2, Recruiting

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

for
Neoplasms, Lung
Location: Montreal, Ottawa, East Syracuse NY, Toronto, Canton OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07099898

Phase 3, Recruiting

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

for
Neoplasms, Prostate
Location: Montreal, New Haven CT, Toronto, East Brunswick NJ,
Sponsor: GlaxoSmithKline

Sex: Male

Age: 18+

Code: NCT06990880

Phase 1, Phase 2, Recruiting

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

for
Neoplasms, Prostate
Location: Toronto, Montreal, Philadelphia PA, Grand Rapids MI,
Sponsor: GlaxoSmithKline

Sex: Male

Age: 18+

Code: NCT07332455

Phase 1, Phase 2, Recruiting

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

for
Liver Diseases, Alcoholic
Location: Montreal, Terrebonne, Toronto, New York NY, Detroit MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70

Code: NCT06613698

Phase 2, Recruiting

Line Dancing With Blood Flow Restriction for Balance and Gait of Older Women (In-Person vs Online)

for
Older Women, Older Adults, Balance, Older Adults,
Location: Montreal
Sponsor: Concordia University, Montreal

Sex: Female

Age: 60+

Code: NCT07860541

Recruiting

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

for
Breast Cancer
Location: Montreal, Oklahoma City OK
Sponsor: Medifocus, Inc.

Sex: Female

Age: 18+

Code: NCT01204801

Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

for
Ulcerative Colitis
Location: Montreal, Rochester NY, Fresh Meadows NY, Chicago IL,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06979336

Phase 2, Recruiting

Exercise to Improve Sleep in Parkinson's Disease

for
Parkinson Disease
Location: Montreal, Laval
Sponsor: McGill University

Sex: All

Age: 40+

Code: NCT05644327

Recruiting

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

for
Discoid Lupus Erythematosus
Location: Montreal, Fredericton
Sponsor: Innovaderm Research Inc.

Sex: All

Age: 18+

Code: NCT06261021

Phase 2, Recruiting